CSL Limited

CSL Limited Stock

15.48P/E
€58.66BMarket capitalisation
-US$5.35Earnings
2.06 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

CSL Limited is registered in the following country: Australia (Exchange: AUASX).

Key metrics

Key metrics and master data for the CSL Limited stock.

Market capitalisation
€58.66B
P/E
15.48
P/B
4.31
P/S
4.06
P/CF
18.22
Issued shares 480M Units

Return

Here you can see the performance of the CSL Limited stock.

PeriodPerfor­mance
1 Week-2.22 %
1 Month+3.57 %
3 Months+31.27 %
6 Months+105.69 %
1 Year+22.00 %
YTD+23.02 %

Dividends

The CSL Limited stock pays an annual dividend. With an (expected) annual dividend of £2.4747, the current stock price results in a dividend yield of 2.06 %.

Dividend typeAnnual dividend
(Expected) annual dividend £2.4747
Dividend yield 2.06 %

Splits

The table shows the splits of the CSL Limited share.

DateRatio
18.10.20073:1

Which ETF contains the CSL Limited stock?

The CSL Limited stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, CSL Limited has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the CSL Limited stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.